Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joshua Asquith"'
Autor:
Ali Sarrami-Foroushani, Toni Lassila, Michael MacRaild, Joshua Asquith, Kit C. B. Roes, James V. Byrne, Alejandro F. Frangi
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
In-silico trials rely on virtual populations and interventions simulated using patient-specific models and may offer a solution to lower costs. Here, the authors present the flow diverter performance assessment in-silico trial, which models the treat
Externí odkaz:
https://doaj.org/article/2e882a4a293141e88a26a43c0ba14cb2
Autor:
James V. Byrne, Toni Lassila, Michael MacRaild, Alejandro F. Frangi, Joshua Asquith, Kit C.B. Roes, Ali Sarrami-Foroushani
Publikováno v:
Nature Communications
Nature Communications, 12
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Nature Communications, 12, 1
Nature Communications, 12
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Nature Communications, 12, 1
The cost of clinical trials is ever-increasing. In-silico trials rely on virtual populations and interventions simulated using patient-specific models and may offer a solution to lower these costs. We present the flow diverter performance assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49041f512d45432aa0b546be25864c43
https://eprints.whiterose.ac.uk/175235/7/s41467-021-23998-w.pdf
https://eprints.whiterose.ac.uk/175235/7/s41467-021-23998-w.pdf
Autor:
Ali Sarrami-Foroushani, Toni Lassila, Michael Macraild, Joshua Asquith, Kit C. B. Roes, James V. Byrne, Alejandro F Frangi
Although the cost of clinical trials is ever-increasing, in-silico trials, which rely on virtual populations and interventions simulated using patient-specificc models, may offer a solution to contain these costs. However, in-silico trial endpoints n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f9c6b93d248ca12237b676bb613f705
https://doi.org/10.21203/rs.3.rs-147836/v1
https://doi.org/10.21203/rs.3.rs-147836/v1